Strata Oncology Stock
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Sign up today and learn more about Strata Oncology Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Strata Oncology Stock
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
Investors
Baird Capital
Pfizer Venture Investments
Wellington Capital Management
Funding History
| June 2016 | $12.0M |
|---|---|
| May 2018 | $26.0M |
| July 2021 | $90.0M |
Management
Co-founder & CEO
Dan Rhodes
Chief Medical Officer, Co-Founder
Scott Tomlins
Chief Financial Officer
Matt Martin
Vice President Clinical Operations
Kat Kwiatkowski
Board of Directors (Observer)
David Gregorka
Board Member, Investor
Jan Garfinkle
Board of Director
Keith Flaherty
Board Member
Nicole Walker
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
